How Global Hemp Trade Could Reshape Farm Economies

Photo by LP_photodesign_16 via Pixabay.

Hemp used to show up in cannabis coverage as a footnote — the boring, non-intoxicating cousin of the plant everyone actually wanted to talk about. That's changing fast, and the numbers explain why. Depending on whose methodology you trust, the industrial hemp market alone sits somewhere around $7.5 billion in 2025, while the broader hemp market that folds in cannabinoid consumables runs closer to $11.4 billion — and both are projected to grow at double-digit rates for years. This is no longer a niche agricultural curiosity. It's a commodity trade story with real ships, real ports, and real tariff codes attached to it.

What makes 2025 and 2026 pivotal isn't just growth — it's a split. Regulators and markets are increasingly treating industrial hemp (fiber, seed, grain, oil) and consumable cannabinoid products (the stuff people vape, eat, or drink for effect) as two fundamentally different categories that happen to come from the same plant genus. The United States just forced that split into the open with a November 2025 federal law redefining hemp in a way that guts the intoxicating-product side of the market while leaving industrial fiber and grain largely untouched. Meanwhile, UNCTAD has been arguing that if global trade classification catches up to this bifurcation, developing countries could finally break into hemp export markets beyond raw fiber. The question worth sitting with isn't whether global hemp trade grows — it probably does, in some form. It's which countries, and which farmers, end up positioned to actually capture that growth as the industrial and consumable economies pull apart.

A Market Bigger and Messier Than the Numbers Suggest

Photo by Mark Stebnicki via Pexels.

Start with the fact that there isn't one hemp market number — there are several, and they disagree by billions of dollars because they're measuring different things. One widely cited methodology puts the global industrial hemp market at $7.5 billion in 2025, climbing to $8.8 billion in 2026, and compounding at roughly 17.9% annually through 2033. That's fiber, seed, and hemp-derived oil — the agricultural commodity side of the plant, sold into textiles, paper, animal feed, construction materials, and cosmetics.

Then there's the broader hemp market figure, which includes cannabinoid consumables like CBD tinctures, hemp-derived beverages, and vape products layered on top of that industrial base. That version pegs 2025 at $11.42 billion, rising to $13.86 billion in 2026, with a much more aggressive 22.77% compound annual growth rate projected out to $71.53 billion by 2034. Notice the gap: nearly $4 billion of difference in 2025 alone, and a growth rate that's five percentage points steeper once consumables are folded in.

That gap isn't sloppy research — it's a proxy for the exact legal ambiguity this piece keeps circling back to. Some analysts count fiber-and-seed hemp and intoxicating cannabinoid products as one continuous market because, botanically, they come from the same crop. Others split them because legally, commercially, and increasingly geopolitically, they behave nothing alike. A bale of hemp fiber bound for a European paper mill faces none of the THC-threshold scrutiny that a hemp-derived beverage does crossing a U.S. state line.

Regionally, Europe has quietly become the center of gravity for the industrial side, holding a 30.96% share of the global industrial hemp market in 2025 — the single largest regional bloc, ahead of North America and Asia. That's worth remembering as the U.S. consumable market goes through regulatory upheaval: Europe's position was built on decades of steady, boring, fiber-and-seed cultivation, not a cannabinoid boom. The growth curves everyone cites assume today's legal patchwork gets sorted out in a way that lets trade scale smoothly. That's an assumption, not a guarantee, and the next several sections are about why.

Who's Actually Growing and Shipping It

Canada, France, Spain/Netherlands, and China each hold an equally weighted, dominant role in a distinct hemp export category, illustrating how global hemp trade leadership is distributed across different countries rather than concentrated in one.

Canada holds the lead in one specific, valuable lane: exporting hemp oil seeds. Decades of legal industrial hemp cultivation under a clear regulatory framework gave Canadian growers a head start on seed genetics and processing infrastructure that newer entrants simply haven't had time to build. It's a small but telling example of how legal stability compounds into commercial advantage over a long enough timeline.

Western Europe, meanwhile, dominates the raw-and-semi-processed end of the trade, with France, Spain, and the Netherlands doing the bulk of the exporting. These aren't necessarily the countries growing the most hemp — they're the ones with the mills, decorticating equipment, and industrial buyers already in place to turn stalks into usable fiber and shive. That processing edge is arguably more durable than raw acreage, since it's harder and slower to replicate.

China is the scale player nobody should overlook. It produces an estimated 35-40% of the world's hemp supply and exports roughly 90% of what it grows, with particular dominance in hemp yarn and textile exports — a category where decades of textile manufacturing infrastructure gave it a natural advantage once hemp fiber demand picked up. China's position here looks less like a cannabis story and more like a continuation of its existing textile export machine, just with a different fiber input.

The more interesting movement is happening at the margins. Between 2019 and 2022, roughly 60 countries reported industrial hemp exports, and about a third of those were developing economies, concentrated in Asia and South America. South American countries have been loosening industrial hemp rules in recent years, and South Africa is emerging as a plausible African hub, helped by favorable growing climate and a liberalizing legal environment. Neither is a major exporter yet — but they're the names showing up in early-stage trade data the way Canada and France did a generation ago.

UNCTAD's June 2026 analysis makes a specific, practical argument about why these emerging players stay stuck exporting raw fiber instead of climbing the value chain: the Harmonized System trade classification codes most countries use don't cleanly distinguish hemp products by processing stage or end use. Clearer HS codes, UNCTAD argues, would let customs authorities and trade negotiators treat processed hemp goods differently from raw fiber, which is a prerequisite for developing countries to build (and get credit for) value-added industries rather than just shipping bales overseas for someone else to process.

The Legal Split That Determines Who Can Even Compete

Photo by Arisa Chattasa via Unsplash.

A global mapping analysis from 2026 turned up a statistic that explains most of the disparities in the previous section: only about one-third of countries clearly separate industrial hemp from drug cannabis in their statutes, while nearly half don't distinguish between the two at all. That's not a legal technicality — it's the single biggest variable determining whether a country's hemp sector can function as agriculture or gets treated, administratively and financially, like a narcotics program.

Think through what that ambiguity actually touches. Cultivation area can't expand if farmers need special narcotics licenses to plant a fiber crop. Export documentation gets flagged at customs when officials can't tell industrial hemp from marijuana on paper. Seed producers won't invest in breeding low-THC, high-fiber cultivars if the legal status of growing them at all is unsettled year to year. Banks and insurers won't extend normal agricultural credit to a crop that sits in regulatory limbo. Universities and ag-extension programs can't run open research on a plant classified as a controlled substance. Each of these frictions compounds, and together they explain why a plant that grows readily in most temperate and subtropical climates remains concentrated in a small number of exporting countries.

The contrast is stark. Canada and much of the EU built out real export infrastructure — processing mills, seed certification systems, dedicated customs codes — precisely because their laws drew a clean line between industrial hemp and drug cannabis early and kept it stable. Countries without that clarity tend to stay stuck running small pilot programs indefinitely, unable to attract the capital or research investment that turns a pilot into an industry.

There's a direct historical precedent for this dynamic, and it's not subtle: the 2018 U.S. Farm Bill. Before that law, hemp cultivation in the U.S. was scattered across state pilot programs with no consistent federal legal footing. The moment the Farm Bill drew a bright legal line — hemp defined as cannabis with no more than 0.3% THC on a dry-weight basis, legally distinct from marijuana — American hemp acreage and processing investment expanded almost overnight. The agronomy didn't change; the legal clarity did. That's the pattern worth extrapolating from: countries that adopt similarly clean industrial-versus-drug definitions in the next few years are reasonable candidates to capture new export share as global demand grows. The catch is that clean statutory language is only half the equation — it also takes enforcement capacity, seed certification systems, and customs infrastructure that many developing economies don't yet have in place, even after the law itself gets fixed.

The U.S. Just Blew Up Its Own Market -- On Purpose

Photo by Maximilianovich via Pixabay.

On November 12, 2025, President Trump signed the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 — an appropriations bill whose name gives no hint that it contains one of the most consequential hemp policy changes since 2018. Tucked inside is a federal redefinition of hemp that fundamentally rewrites how legal THC content gets measured and capped.

The mechanics matter. The new law shifts the measurement standard to total THC, which includes THCA — the non-intoxicating acidic precursor that converts to active THC when heated. That's a meaningful technical correction, since it aligns legal measurement with how labs actually quantify what a consumer ends up absorbing after combustion or vaporization; under the old 0.3% delta-9 THC standard, plenty of products with high THCA content could technically pass as legal hemp despite becoming fully psychoactive once smoked. Alongside that, the law caps finished consumable products at 0.4 milligrams of total THC per container — an extremely low ceiling — and bans synthesized cannabinoids outright, targeting the delta-8 and similar lab-converted products that built an entire retail category out of the 2018 bill's loopholes.

Congress built in a 365-day transition window, so the law takes effect November 12, 2026, unless lawmakers delay or repeal it before then — and multiple efforts to do exactly that are already underway. Forbes has estimated the law, as written, threatens a $28.4 billion industry and roughly 300,000 jobs, concentrated almost entirely on the consumable cannabinoid side rather than industrial fiber and grain, which the 0.4 mg cap doesn't meaningfully touch.

The pushback is real and bipartisan. The Hemp Planting Predictability Act would push the effective date out to November 2028, giving the industry more runway to adapt. Senators Wyden and Merkley have introduced the Cannabinoid Safety and Regulation Act as a regulatory alternative — an attempt to police the consumable market through safety standards rather than a near-total THC cap. And the House Agriculture Committee's version of the 2026 Farm Bill (H.R. 7567/H.R. 5371, which cleared committee 34-17 on March 5, 2026) takes a notably different approach: it explicitly separates industrial hemp from consumable cannabinoid products in statute and would direct USDA to ease testing and background-check requirements specifically for industrial growers — essentially codifying the fiber-versus-consumable split this whole piece has been describing.

States aren't waiting for Congress to sort this out. Ohio enacted a categorical ban on intoxicating hemp products in December, adding to a patchwork where a hemp beverage legal in one state can be contraband a few miles across a state line. That state-level divergence is its own variable — even if Congress delays the federal effective date, individual states can still choke off the consumable market on their own timeline.

What This Means for Farmers and Trade Partners Elsewhere

Photo by Chris F via Pexels.

If the U.S. consumable-cannabinoid market contracts or fractures state by state — which looks increasingly plausible given the November 2025 law and Ohio's ban — capital and processing demand don't just vanish. Some of it plausibly migrates toward jurisdictions with clearer legal separation between industrial and consumable hemp. Canada, the major EU exporters, and emerging players like South Africa are the most obvious candidates to absorb that shift, precisely because they've already done the legal groundwork the U.S. is only now attempting through the Farm Bill split.

The optimistic case has real supporting evidence behind it. UNCTAD's push for clearer HS trade classification codes, combined with the roughly one-third of the 60-odd hemp-exporting countries between 2019 and 2022 that were developing economies, suggests there's a plausible path for countries in South America, South Asia, and Africa to move up the value chain — from selling raw fiber bales to exporting processed textiles, hempcrete blocks, or refined oil. If the legal and classification infrastructure catches up, that's a genuine growth opportunity, not just a hopeful narrative.

The conservative counter-case deserves equal weight, though, and it's the one growth projections tend to gloss over: the United States is still the largest single hemp and cannabinoid consumer market in the world. A serious U.S. contraction might not redirect global demand elsewhere so much as simply shrink it. Those 17-23% compound annual growth rate projections cited earlier assumed a legal and commercial environment that no longer exists as of November 2025. If the American consumable segment collapses anywhere close to Forbes' $28.4 billion estimate, the honest expectation is that industry-wide growth softens meaningfully, not that some other country neatly inherits that lost demand.

For the optimistic scenario to actually play out, a lot of unglamorous infrastructure work has to happen first. Canada and the EU didn't build export-grade processing capacity, certified seed genetics, or customs logistics in a single growing season — it took years of stable policy and steady investment. Any country hoping to absorb displaced U.S. demand needs that same foundation, and foundations don't get poured overnight just because a market opportunity appears.

In the meantime, a few concrete business angles look more resilient than the consumable-product gold rush that's currently under regulatory siege: contract processing and toll manufacturing for industrial fiber and grain, which sidesteps THC-cap risk entirely; hemp-based building materials like hempcrete and fiberboard, which serve construction markets largely indifferent to cannabinoid politics; and textile-grade hemp yarn, a category where China's existing dominance sets a high bar but where rising raw-material costs elsewhere could open room for competitors with cheaper land and labor.

Strip away the headlines about vape bans and THC caps, and the durable growth story in global hemp is almost aggressively unglamorous: fiber for textiles, seed for grain and oil, and increasingly, building materials like hempcrete and fiberboard. None of that depends on where a legislature draws a THC line for consumable products, because none of it involves getting anyone high. That's precisely why it's the more investable long-term bet, even though it will never generate the headlines that a $28.4 billion consumable-market threat does.

If there's one leading indicator worth tracking over the next five to ten years, it's legal classification — not consumer trends, not even acreage figures. Countries that cleanly separate industrial hemp from drug cannabis in statute, the way Canada and much of the EU did years ago, are the ones that will keep attracting seed genetics investment, processing infrastructure, and export logistics. Countries stuck in the roughly two-thirds bucket that either blur the line or don't draw one at all will keep producing anecdotes about hemp's potential rather than actual trade volume.

The U.S. redefinition taking effect in November 2026 amounts to a forced, real-time experiment that other legislatures are watching closely, whether or not they'd admit it. How Congress ultimately resolves the tension between the Hemp Planting Predictability Act's delay, the Wyden-Merkley regulatory alternative, and the House Agriculture Committee's industrial-versus-consumable split in the 2026 Farm Bill will likely become the next reference point other countries cite when writing their own hemp statutes — the same way the 2018 Farm Bill's 0.3% THC threshold became a template copied, argued over, and adapted well beyond U.S. borders. Whoever gets that split right first probably doesn't just fix their own market. They write the next decade's rulebook for everyone else's.